Stockreport

Immunomedics reports Q4 results [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF Immunomedics (NASDAQ: IMMU ): Q4 EPS of -$0.48 Revenue of $0.6M (+11.1% Y/Y) Press Release Now read: Reata Pharmaceuticals misses by $0.22, beats on rev [Read more]